8-K

RCM TECHNOLOGIES, INC. (RCMT)

8-K 2023-08-09 For: 2023-08-09
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  August 9, 2023

RCM Technologies, Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada<br><br> <br>(State or Other<br><br> <br>Jurisdiction of<br><br> <br>Incorporation) 1-10245<br><br> <br>(Commission File<br><br> <br>Number) 95-1480559<br><br> <br>(I.R.S. Employer<br><br> <br>Identification No.)
2500 McClellan Avenue, Suite 350
--- ---
Pennsauken, NJ 08109-4613
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (856) 356-4500

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)).

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.05 per share RCMT The NASDAQ Stock Market LLC

Item 2.02.       Results of Operations and Financial Condition.

On August  9, 2023, the Registrant issued a press release regarding its financial results for the thirteen and twenty-six weeks ended July 1, 2023.  A copy of the press release is furnished as Exhibit 99 to this report.

The information set forth under this “Item 2.02. Results of Operations and Financial Condition” (including the exhibit) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Registrant pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto.

Item 9.01.       Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

None.

(b) Pro Forma Financial Information.

None.

(c) Shell Company Transactions.

None.

(d) Exhibits.

Exhibit Number
99 Press Release by the Registrant, dated August 9, 2023, furnished in accordance with Item 2.02 of this Current Report on Form 8-K.
104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RCM TECHNOLOGIES, INC.

By: /s/ Kevin D. Miller
Kevin D. Miller
Chief Financial Officer, Treasurer and<br><br> <br>Secretary

Dated: August 9, 2023

ex_554820.htm

Exhibit 99

rcm01.jpg

RCM Technologies, Inc. Tel: 856.356.4500 Corporate Contacts:
2500 McClellan Avenue Fax: 856.356.4600 Bradley S. Vizi
Pennsauken, NJ 08109 info@rcmt.com Executive Chairman
www.rcmt.com Kevin D. Miller
Chief Financial Officer

P R E S S   R E L E A S E

RCM TECHNOLOGIES, INC. ANNOUNCES

SECOND-QUARTER RESULTS

Pennsauken, NJ – August 9, 2023 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and twenty-six weeks ended July 1, 2023.

RCM Technologies reported revenue of $67.0 million for the thirteen weeks ended July 1, 2023 (the current period), a decrease of 9.8% compared to $74.3 million for the thirteen weeks ended July 2, 2022 (the comparable prior-year period). Gross profit was $18.8 million for the current period, a 13.5% decrease compared to $21.7 million for the comparable prior-year period.  The Company experienced GAAP operating income of $5.7 million for the current period compared to $8.2 million for the comparable prior-year period.  The Company experienced GAAP net income of $4.0 million, or $0.47 per diluted share, for the current period compared to $6.0 million, or $0.57 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA (non-GAAP) of $6.0 million for the current period compared to $8.4 million for the comparable prior-year period.

RCM Technologies reported revenue of $134.2 million for the twenty-six weeks ended July 1, 2023 (the current period), a decrease of 14.2% compared to $156.3 million for the twenty-six weeks ended July 2, 2022 (the comparable prior-year period). Gross profit was $37.8 million for the current period, a 16.2% decrease compared to $45.1 million for the comparable prior-year period.  The Company experienced GAAP operating income of $11.5 million for the current period compared to $17.2 million for the comparable prior-year period.  The Company experienced GAAP net income of $7.8 million, or $0.87 per diluted share, for the current period compared to $12.5 million, or $1.18 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA (non-GAAP) of $11.7 million for the current period compared to $17.7 million for the comparable prior-year period.

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “Despite a slow start to the year in Engineering, we made the decision to maintain stride in building what we believe to be a highly differentiated platform in the professional service marketplace. Our decision was supported by our view of the secular growth markets and our strong portfolio of capabilities, and we now see the business continuing to strengthen as we move through the year.”


Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “We believe our strong cash generating business model and clean balance sheet afford us the ability to invest in value accretive growth throughout the economic cycle. Considering normal third quarter seasonality, we believe we are set up for a healthy double-digit earnings increase in the fourth quarter, consistent with our long-term trajectory. Also, we expect to continue to see strong cash flow from operations during the second half of fiscal 2023.”

Conference Call

On Thursday, August 10, 2023, RCM Technologies will host a conference call to discuss these results. The call will begin at 11:30 a.m. Eastern Time. The dial-in number is (800) 285-6670.

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. **** RCM is an innovative leader in delivering these solutions to commercial and government sectors. RCM is also a **** provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America and Serbia. Additional information can be found at www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow


RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Per Share Amounts)

Thirteen Weeks Ended
July 1, 2023 July 2, 2022
Revenue $67,035 74,346
Cost of services 48,275 52,663
Gross profit 18,760 21,683
Selling, general and administrative 12,723 13,264
Depreciation and amortization of property and equipment 242 225
Amortization of acquired intangible assets 46 -
Operating income 5,749 8,194
Other expense (income), net 418 (28
Income before income taxes 5,331 8,222
Income tax expense 1,348 2,208
Net income $3,983 6,014
Diluted net earnings per share data $0.47 0.57
Diluted weighted average shares outstanding 8,558,396 10,550,896

All values are in US Dollars.

Twenty-Six Weeks Ended
July 1, 2023 July 2, 2022
Revenue 134,159 $156,307
Cost of services 96,375 111,204
Gross profit 37,784 45,103
Selling, general and administrative 26,119 27,411
Depreciation and amortization of property and equipment 513 463
Amortization of acquired intangible assets 91 -
Gain on sale of assets (395 -
Operating income 11,456 17,229
Other expense, net 825 24
Income before income taxes 10,631 17,205
Income tax expense 2,811 4,671
Net income 7,820 $12,534
Diluted net earnings per share data 0.87 $1.18
Diluted weighted average shares outstanding 8,976,714 10,583,519

All values are in US Dollars.


RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  Adjusted operating income, EBITDA and Adjusted EBITDA should not be considered alternatives to net income as an indicator of performance.  In addition, Adjusted operating income, EBITDA and Adjusted EBITDA do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA and Adjusted EBITDA for the thirteen and twenty-six weeks ended July 1, 2023 and July 2, 2022.

Thirteen Weeks Ended Twenty-Six Weeks Ended
July 1,<br> 2023 July 2,<br> 2022 July 1,<br> 2023 July 2,<br> 2022
GAAP net income 3,983 6,014 7,820 12,534
Income tax expense 1,348 2,208 2,811 4,671
Interest expense, net 425 69 785 166
Depreciation of property and equipment 242 225 513 463
Amortization of acquired intangible assets 46 - 91 -
EBITDA (non-GAAP) 6,044 8,516 12,020 17,834
Adjustments
Gain on sale of assets - - (395 -
(Gain) loss on foreign currency transactions (7 (97 40 (142
Adjusted EBITDA (non-GAAP) 6,037 8,419 11,665 17,692

All values are in US Dollars.


RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

Thirteen Weeks Ended July 1, 2023
Specialty<br> Health Care Engineering Life Sciences<br> and IT Consolidated
Revenue 35,528 21,014 10,493 67,035
Cost of services 25,727 16,192 6,356 48,275
Gross profit 9,801 4,822 4,137 18,760
Gross profit margin 27.6 22.9 39.4 28.0

All values are in US Dollars.

Thirteen Weeks Ended July 2, 2022
Specialty<br> Health Care Engineering Life Sciences<br> and IT Consolidated
Revenue 43,457 20,906 9,983 74,346
Cost of services 30,575 15,395 6,693 52,663
Gross profit 12,882 5,511 3,290 21,683
Gross profit margin 29.6 26.4 33.0 29.2

All values are in US Dollars.

Twenty-Six Weeks Ended July 1, 2023
Specialty<br> Health Care Engineering Life Sciences<br> and IT Consolidated
Revenue 74,658 39,504 19,997 134,159
Cost of services 53,185 30,365 12,555 96,375
Gross profit 21,473 8,869 7,442 37,784
Gross profit margin 28.8 22.5 37.2 28.2

All values are in US Dollars.

Twenty-Six Weeks Ended July 2, 2022
Specialty<br> Health Care Engineering Life Sciences<br> and IT Consolidated
Revenue 95,641 40,804 19,862 156,307
Cost of services 67,758 30,059 13,387 111,204
Gross profit 27,883 10,745 6,475 45,103
Gross profit margin 29.2 26.3 32.6 28.9

All values are in US Dollars.


RCM Technologies, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In Thousands, Except Share Amounts)

July 1, December 31,
2023 2022
(Unaudited)
Current assets:
Cash and cash equivalents $1,273 $339
Accounts receivable, net 61,614 50,762
Transit accounts receivable 9,875 3,280
Prepaid expenses and other current assets 4,324 4,636
Total current assets 77,086 59,017
Property and equipment, net 2,158 2,098
Other assets:
Deposits 169 173
Goodwill 22,147 22,147
Operating right of use asset 3,203 3,665
Intangible assets, net 774 864
Total other assets 26,293 26,849
Total assets $105,537 $87,964
Current liabilities:
--- --- --- --- ---
Accounts payable and accrued expenses 12,947 14,147
Transit accounts payable 37,190 9,767
Accrued payroll and related costs 11,836 13,023
Finance lease payable 464 462
Income taxes payable 233 85
Operating right of use liability 1,091 1,349
Contingent consideration from acquisitions 300 472
Deferred revenue 504 1,119
Total current liabilities 64,565 40,424
Deferred income taxes, net, foreign 169 166
Deferred income taxes, net, domestic 1,599 1,495
Finance lease payable - 232
Contingent consideration from acquisitions, net of current position 1,671 1,970
Operating right of use liability, net of current position 2,508 2,932
Borrowings under line of credit 14,851 8,783
85,363 56,002
Stockholders’ equity:
Preferred stock, 1.00 par value; 5,000,000 shares authorized;
no shares issued or outstanding - -
Common stock, 0.05 par value; 40,000,000 shares authorized;
17,516,469 shares issued and 7,934,088 shares outstanding at<br><br> <br>July 1, 2023 and 17,287,967 shares issued and 9,285,318 shares<br><br> <br>outstanding at December 31, 2022 873 863
Additional paid-in capital 115,314 113,878
Accumulated other comprehensive loss (2,857 (2,863
Accumulated deficit (28,276 (36,096
Treasury stock, 9,582,381 shares at July 1, 2023 and
8,002,649 shares at December 31, 2022, at cost (64,880 (43,820
Total stockholders’ equity 20,174 31,962
Total liabilities and stockholders’ equity 105,537 87,964

All values are in US Dollars.


RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

Thirteen Weeks Ended
July 1,<br> 2023 July 2,<br> 2022
Net income 3,983 6,014
Adjustments to reconcile net income to cash<br><br> <br>used in operating activities 1,043 449
Changes in operating assets and liabilities:
Accounts receivable (2,804 13,779
Prepaid expenses and other current assets (648 343
Net of transit accounts receivable and payable 19,356 (731
Accounts payable and accrued expenses 654 389
Accrued payroll and related costs (3,598 (2,392
Right of use liabilities (335 (382
Income taxes payable 6 1,111
Deferred revenue (305 (315
Deposits (9 9
Total adjustments 13,360 12,260
Net cash provided by operating activities 17,343 18,274
Net cash used in investing activities (227 (223
Net cash used in financing activities (18,160 (15,563
Effect of exchange rate changes on cash and cash equivalents (37 (235
Increase in cash and cash equivalents (1,081 2,253
Common stock repurchase (12,876 (2,781

All values are in US Dollars.

Twenty-Six Weeks Ended
July 1,<br> 2023 July 2,<br> 2022
Net income 7,820 12,534
Adjustments to reconcile net income to cash<br><br> <br>used in operating activities 1,746 1,186
Changes in operating assets and liabilities:
Accounts receivable (10,839 3,565
Prepaid expenses and other current assets 312 434
Net of transit accounts receivable and payable 20,828 (210
Accounts payable and accrued expenses (1,013 (585
Accrued payroll and related costs (1,194 3,048
Right of use liabilities (683 (926
Income taxes payable 147 2,935
Deferred revenue (615 (1,237
Deposits 2 11
Total adjustments 8,691 8,221
Net cash provided by operating activities 16,511 20,755
Net cash used in investing activities (559 (453
Net cash used in financing activities (15,215 (17,175
Effect of exchange rate changes on cash and cash equivalents 197 (250
Increase in cash and cash equivalents 934 2,877
Common stock repurchase (21,060 (2,781

All values are in US Dollars.